GME Meeting Planner

Psychiatry Update 2020
Access this week's program here: https://www.engagez.net/psych-update-2020
Jointly provided by Global Medical Education and the Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from Allergan, Eisai, Intra-Cellular Therapies, Jazz Pharmaceuticals, Neurocrine Biosciences, Sunovion, and Takeda.
*Due to COVID-19, GME has moved this series from live, in-person meetings to a series of five (5) virtual webcasts throughout the fall. All currently registered attendees will be transferred to one of five dates and notified via email. We will be welcoming additoinal registrations for all webcasts. Please email us at [email protected] if you have any questions.
The GME Psychiatry Update will highlight the latest advances in diagnostic and therapeutic issues in ADHD, schizophrenia, sleep disorders, bipolar disorders and more. This meeting offers up to 6+ hours of CME/CE credits.
Overview


Jointly provided by Postgraduate Institute for Medicine and Global Medical Education.
This activity is supported by independent educational grants from Allergan, Eisai, Intra-Cellular Therapies, Jazz Pharmaceuticals, Neurocrine Biosciences, Sunovion, and Takeda.
Target Audience
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists and psychologists engaged in the care of patients with psychiatric disorders.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss the diagnosis and management of adult ADHD
- Discuss the unmet needs in bipolar disorders
- Describe the use of innovative treatments for TD
- Encourage the use of evidence-based treatments for bipolar and sleep disorders
- Individualize treatment choices, giving consideration to efficacy, safety, long-term data.
Faculty
Milton Erman, MD
Voluntary Clinical Professor in the Department of Psychiatry,
School of Medicine of the University of California, San Diego
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry,
Icahn School of Medicine, Mount Sinai
Sanjay Gupta, MD
Clinical Professor of Psychiatry
SUNY Buffalo
John M. Kane, MD
Chairman of Psychiatry
Hofstra Northwell School of Medicine
Prakash Masand, MD
Chairman and CEO, Global Medical Education
Adjunct Professor, Duke-National University of Singapore Medical School
Sanjay J. Mathew, MD
Professor of Psychiatry and Behavioral Sciences
Baylor College of Medicine
Greg Mattingly, MD
Associate Clinical Professor,
Washington University School of Medicine
Joseph P. McEvoy, MD
Case Distinguished Professor of Psychiatry
Augusta University Health
Jonathan Meyer, MD
Clinical Professor of Psychiatry,
University of California, San Diego
Anthony Rostain, MD
Professor of Psychiatry and Pediatrics,
Perelman School of Medicine
Thomas Scammell, MD
Professor of Neurology,
Harvard Medical School
Michael J. Thorpy, MD
Professor of Clinical Neurology,
Montefiore Medical Center
Phyllis Zee, MD, PhD
Chief, Division of Sleep Medicine,
Northwestern University, Feinberg School of Medicine
Program Agenda
Welcome Remarks – 15 minutes
Managing Bipolar Spectrum Across the Lifecycle – 1 hour
Break
Non-CME Educational talk – 1 hour
Break
Tardive Dyskinesia: A Primer for Clinicians – 1 hour
Innovations in Managing Insomnia Across the Lifecycle – 1 hour
Break
Non-CME Educational talk – 1 hour
Break
Recent Advances in Treating Schizophrenia – 1 hour
Management of Narcolepsy and Obstructive Sleep Apnea in Psychiatric Patients – 1 hour
Adult ADHD in Practice: Are We Missing It? – 1 hour
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 6 contact hours (0.6 CEU) of the Accreditation Council for Pharmacy Education.
Universal Activity Number –JA4008162-9999-20-2276-L01-P
Type of Activity: Application
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 6 contact hours. Designated for 2.6 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 6 contact hours.
AAPA Credit Designation Statement
This activity is designated for 6 AAPA Category 6 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Psychologist Education
Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility of the program.
Credit Designation
This program offers 6.0 continuing education credits for psychologists.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty
Milton Erman, MD
Fees for Non-CME/CE Services Received Directly from a Commercial Interest
or their Agents (e.g., speakers’ bureaus): Jazz, Merck
Joseph F. Goldberg, MD
Consulting fees: BioXcel, Otsuka, Sage
Fees for Non-CME/CE Services Received Directly from a Commercial Interest
or their Agents (e.g., speakers’ bureaus): Allergan, Intra-Cellular Therapies, Otsuka, Sunovion
Sanjay Gupta, MD
Fees for Non-CME/CE Services Received Directly from a Commercial Interest
or their Agents (e.g., speakers’ bureaus): Janssen, Otsuka, Neurocrine Biosciences, Sunovion, AbbVie, Indivor, Intra-Cellular Therapies, Alkermes
John M. Kane, MD
Consulting Fees: Acadia, Alkermes, Allergan, Dainippon Sumitomo, Lundbeck, Intra-Cellular Therapies, Janssen Pharmaceuticals, Johnson & Johnson, LB Pharmaceuticals, Merck, Minerva, Neurocrine Biosciences, Otsuka, Reviva, Roche, Saladex, Sunovion, Takeda, Teva
Ownership Interest less than 5% (stocks, stock options, or other ownership interest excluding diversified mutual funds): LB Pharmaceuticals
Prakash Masand, MD
Consultant: Acadia, Allergan, Intra-Cellular Therapies, Lundbeck, Sunovion, Takeda
Research Support: Allergan
Fees for Non-CME/CE Services Received Directly from a Commercial Interest
or their Agents (e.g., speakers’ bureaus): Allergan, Intra-Cellular Therapies, Lundbeck, Sunovion, Takeda
Shareholder: Centers for Psychiatric Excellence (COPE), Global Medical Education
Sanjay J. Mathew, MD
Consulting Fees: Axsome, Clexio, Janssen, Perception, Sage Therapeutics
Contracted Research: Biohaven
Greg Mattingly, MD
Consulting Fees: AbbVie, Acadia, Alkermes, Axsome, Eisai, Ironshore, Intra-Cellular Therapies, Janssen, Lundbeck, Neos, Neurocrine Biosciences, Otsuka, Redax, Roche, Rhodes, Sage, Shire, Sunovion, Supernus, Takeda, Teva, Trispharma
Fees for Non-CME/CE Services Received Directly from a Commercial Interest
or their Agents (e.g., speakers’ bureaus): AbbVie, Acadia, Alkermes, Axsome, Eisai, Ironshore, Intra-Cellular Therapies, Janssen, Lundbeck, Neos, Neurocrine Biosciences, Otsuka, Redax, Roche, Rhodes, Sage, Shire, Sunovion, Supernus, Takeda, Teva, Trispharma
Contracted Research: AbbVie, Acadia, Alkermes, Avanir, Axsome, Boehringer, Emalex, Janssen, Medgenics, NLS-1 Pharma AG, Redax, Roche, Sage, Shire, Sunovion, Supernus, Takeda, Teva
Joseph P. McEvoy, MD
Contracted Research: Auspex, Alkermes, Biogen
Jonathan Meyer, MD
Consulting Fees: Acadia Pharmaceuticals, Alkermes, Allergan (now AbbVie), Intra-Cellular Therapies, Neurocrine Biosciences
Fees for Non-CME/CE Services Received Directly from a Commercial Interest
or their Agents (e.g., speakers’ bureaus): Acadia Pharmaceuticals, Alkermes, Allergan (now AbbVie), Intra-Cellular Therapies, Neurocrine Biosciences, Otsuka America, Inc., Sunovion Pharmaceuticals, Teva
Anthony Rostain, MD
Consulting Fees: Arbor, Tris, Shire/Takeda, National Football League
Thomas Scammell, MD
Consulting Fees: Accelerator, Alkermes, Avadel, Consynance, Harmony Biosciences, Idorsia, Jazz
Contracted Research: Takeda, Merck
Michael J. Thorpy, MD
Consulting Fees: Axsome, Balance Therapeutics, Flamel/Avadel, Harmony Biosciences, Jazz Pharmaceuticals, Suven Life Sciences Ltd., Takeda Pharmaceuticals, Eisai
Phyllis Zee, MD, PhD
Consulting Fees: Eisai, Philips, Jazz, Pear Therapeutics, Takeda, Sanofi-Aventis, Merck
Contracted Research: Philips, Apnimed
Ownership Interest less than 5% (stocks, stock options, or other ownership interest excluding diversified mutual funds): Teva
Planners and Managers
The Global Medical Education planner and managers have nothing to disclose.
The PIM planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Request for Credit
In order to obtain your CME/CE certificate, please follow the steps below at the conclusion of the webinar:
- Go to www.cmeuniversity.com
- Login or Create a New Account (will take less than 1 minute)
- If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forget My Password link to have your Username and Password sent to you via email
- If you already have a PowerPak account, you can use those credentials to login to CMEU
- After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
- Type in 15031 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
- Click on the activity title when it appears
- Choose the type of credit you desire – please note that “APA” credit is American Psychological Association for psychologists.
- Complete the online Evaluation
- Receive an immediate CME/CE Certificate to download and/or print for your files
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check your NABP account within thirty (30) days to make sure the credit has posted.
If you have questions regarding the certification of this activity, please contact PIM via email at [email protected].
Program Agenda
Confirmed topics include:
- Managing Bipolar Spectrum Across the Lifecycle
- Tardive Dyskinesia: A Primer for Clinicians
- Innovations in Managing Insomnia Across the Lifecycle
- Recent Advances in Treatng Schizophrenia
- Management of Narcolepsy and Obstructive Sleep Apnea in Psychiatric Patients
- Adult ADHD in Practice: Are We Missing It?
*Please scroll down for specific agendas for each meeting. All times are listed in ET.
Agenda for Sept 26 and October 24 meetings (later start time for west coast audience)
10:45 – 11:00 AM: Welcome Remarks
11:00 – 12:00 PM: “Managing Bipolar Spectrum Across the Lifecycle”
-short break-
12:00 – 1:00 PM: Non-CME Educational talk
1:00 – 1:15 PM Break
1:15 – 2:15 PM: “Tardive Dyskinesia: A Primer for Clinicians”
2:15 – 3:15 PM: “Innovations in Managing Insomnia Across the Lifecycle”
-short break-
3:15 – 4:15 PM: Non-CME Educational talk
4:15 – 4:30 PM: Break
4:30 – 5:30 PM: “Recent Advances in Treating Schizophrenia”
5:30 – 6:30 PM: Management of Narcolepsy and Obstructive Sleep Apnea in Psychiatric Patients”
6:30 – 7:30 PM: “Adult ADHD in Practice: Are We Missing It?”
Agenda for Oct 3 and Oct 17 meetings (earlier start time for east coast audience)
8:45 – 9:00 AM: Welcome Remarks
9:00 – 10:00 AM: “Managing Bipolar Spectrum Across the Lifecycle”
-short break-
10:00 – 11:00 AM: Non-CME Educational talk
11:00 – 11:15 AM Break
11:15 – 12:15 PM: “Tardive Dyskinesia: A Primer for Clinicians”
12:15 –1:15 PM: “Innovations in Managing Insomnia Across the Lifecycle”
-short break-
1:15 – 2:15 PM: Non-CME Educational talk
2:15 – 2:30 PM: Break
2:30 – 3:30 PM: “Recent Advances in Treating Schizophrenia”
3:30 – 4:30 PM: Management of Narcolepsy and Obstructive Sleep Apnea in Psychiatric Patients”
4:30 – 5:30 PM: “Adult ADHD in Practice: Are We Missing It?”
Agenda for Oct 10 meeting
8:45 – 9:00 AM: Welcome Remarks
9:00 – 10:00 AM: “Managing Bipolar Spectrum Across the Lifecycle”
-short break-
10:00 – 11:00 AM: Non-CME Educational talk
11:00 – 11:15 AM Break
11:15 – 12:15 PM: “Tardive Dyskinesia: A Primer for Clinicians”
12:15 –1:15 PM: “Innovations in Managing Insomnia Across the Lifecycle”
-short break-
1:15 – 2:15 PM: Non-CME Educational talk
2:15 – 2:30 PM: Break
2:30 – 3:30 PM: “Recent Advances in Treating Schizophrenia”
-short break-
3:30 – 4:30 PM: Non-CME Educational talk
4:30 – 4:45 PM: Break
4:45 – 5:45 PM: Management of Narcolepsy and Obstructive Sleep Apnea in Psychiatric Patients”
5:45 – 6:45 PM: “Adult ADHD in Practice: Are We Missing It?”